Core to Evidence-Based Health Policy
cost-effectiveness evaluation for future healthcare
C2H is the only public research organization
for official cost-effectiveness evaluation process
in Japan
![C2H LOGO](https://c2h.niph.go.jp/en/images/7fb3786a0f1d6bb0a519986466db68d952e88c3c.png)
C2H (Center for Outcomes Research and Economic Evaluation for Health) is an organization of National Institute of Public Health; it conducts academic analysis of cost-effectiveness evaluation from the scientific viewpoint. This website will dispatch information about cost-effectiveness evaluation in Japan. We are happy if this website contributes to evidence-based health policy (EBHP).
Tools for cost-effectiveness evaluation
Latest news
-
news
New C2H Report: Tezepelumab (Tezspire)
Report of the cost-effectiveness evaluation on Tezepelumab (Tezspire) was released.
-
news
New C2H Report: Deucravacitinib (Sotyktu)
Report of the cost-effectiveness evaluation on Deucravacitinib (Sotyktu) was released.
-
news
New C2H Report: Molnupiravir (Lagevrio)
Report of the cost-effectiveness evaluation on Molnupiravir (Lagevrio) was released.